The firm’s P53Diicbiome advancement enables very early discovery of individuals in jeopardy of cancer-related issues.
FEMTO Research Study Team Co., Ltd. Solution Advancement in Thailand at the 2025 Medical Care Asia Honors for its introducing operate in cancer cells screening and COVID-19 and COVID-19 and genome research study.
Arising research study reveals that cancer cells people are vulnerable to extreme Covid-19 results 3 times as long as extreme Covid-19 outcomes since the body immune system has actually been endangered. Additionally, current searchings for recommend that the SARS-COV-2 infection might be incorporated right into the human genome, possibly causing the growth of brand-new cancers cells or aggravating current illness.
The FEMTO research study group has actually gone to the center of this exploration. Throughout the Covid-19 pandemic, the firm’s scientists discovered that 23% of the people evaluated had viral genome assimilation.
At the heart of the success of the FEMTO research study team is its p53microbiome and p53diicbiome Technologies, which have actually won the Medical care Asia Solution Advancement Honor for 7 successive years from 2018 to 2024.
These technologies make use of DNA drawn out from completely dry saliva, noninvasively on cotton pads in the house, and delivered to FEMTO laboratories for evaluation. This approach enables very early discovery of genomic infections related to cancer cells, supplying hassle-free and hassle-free services for at-risk people.
Making Use Of the P53Diicbiome 2025 advancement, people with SARS-COV-2 infection assimilation can be determined prior to signs show up. This will certainly make it possible for doctor to take care of, reduce or avoid extreme cancer-related issues. On the other hand, those that have actually been identified with cancer cells can obtain even more customized therapy strategies based upon their genome account.
By recognizing viral genome assimilation, medical professionals can likewise much better anticipate regressions, issues, and illness development.
As it remains to establish cutting-edge services, FEMTO Study Team Co., Ltd. The future of cancer cells medical diagnosis, client treatment and clinical advancement is being formed.
The Eastern Medical care Honors redefines health centers of quality in the area via its cutting-edge services and considerable payments to the area that redefine the market’s criteria of quality.
The Eastern Medical care Honor exists by Medical care Asia Publication. To check out the complete listing of victors, click right here. If you wish to sign up with the 2026 Honors Event and are applauded for your company’s exceptional campaigns and payments to the health care market, please get in touch with JulieAnne Nuñez julie@charltonmediamail.com.
